# CRISPR Therapeutics AG: insider transactions

CRSP · Nasdaq · CIK 1674416 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crsp.md) · [Financials](/companies/crsp/financials.md) · [Filings](/companies/crsp/filings.md) · [Insiders](/companies/crsp/insiders.md)

## All transactions: 9

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2018-12-27 | [Vertex Pharmaceuticals (Europe) Ltd](/insiders/1761216.md) | 10% owner | Purchase (P) | 27,461 | $24.9487 | $685.1k | [Form 4](/filings/0001209191-18-064322.md) |
| 2018-12-26 | [Vertex Pharmaceuticals (Europe) Ltd](/insiders/1761216.md) | 10% owner | Purchase (P) | 12,737 | $24.8942 | $317.1k | [Form 4](/filings/0001209191-18-064322.md) |
| 2018-12-24 | [Vertex Pharmaceuticals (Europe) Ltd](/insiders/1761216.md) | 10% owner | Purchase (P) | 53,655 | $24.9687 | $1.3m | [Form 4](/filings/0001209191-18-064099.md) |
| 2018-12-24 | [Vertex Pharmaceuticals (Europe) Ltd](/insiders/1761216.md) | 10% owner | Purchase (P) | 11,742 | $23.1766 | $272.1k | [Form 4](/filings/0001209191-18-064099.md) |
| 2018-12-24 | [Vertex Pharmaceuticals (Europe) Ltd](/insiders/1761216.md) | 10% owner | Purchase (P) | 2,603 | $22.9147 | $59.6k | [Form 4](/filings/0001209191-18-064099.md) |
| 2018-12-21 | [Vertex Pharmaceuticals (Europe) Ltd](/insiders/1761216.md) | 10% owner | Purchase (P) | 22,742 | $22.5784 | $513.5k | [Form 4](/filings/0001209191-18-064099.md) |
| 2016-10-24 | [Glaxosmithkline plc](/insiders/1131399.md) | 10% owner | Purchase (P) | 66,500 | $14.00 | $931.0k | [Form 4](/filings/0000903423-16-001320.md) |
| 2016-10-24 | [Glaxosmithkline plc](/insiders/1131399.md) | 10% owner | Conversion (C) | 211,567 | not reported | not reported | [Form 4](/filings/0000903423-16-001320.md) |
| 2016-10-24 | [Glaxosmithkline plc](/insiders/1131399.md) | 10% owner | Conversion (C) | 2,942,560 | not reported | not reported | [Form 4](/filings/0000903423-16-001320.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 2, 2026, 20:24 ET. No prices; not investment advice.